139 related articles for article (PubMed ID: 14571743)
1. Effects of propionyl-L-carnitine topical irrigation in distal ulcerative colitis: a preliminary report.
Gasbarrini G; Mingrone G; Giancaterini A; De Gaetano A; Scarfone A; Capristo E; Calvani M; Caso V; Greco AV
Hepatogastroenterology; 2003; 50(53):1385-9. PubMed ID: 14571743
[TBL] [Abstract][Full Text] [Related]
2. Effects of propyonil-l-carnitine topical irrigation in distal ulcerative colitis: a preliminary report.
Giancaterini A; Mingrone G; De Gaetano A; Capristo E; Calvani M; Caso V; Greco AV; Gasbarrini G
Am J Gastroenterol; 2001 Jul; 96(7):2275-6. PubMed ID: 11467678
[No Abstract] [Full Text] [Related]
3. Randomised clinical trial: the efficacy and safety of propionyl-L-carnitine therapy in patients with ulcerative colitis receiving stable oral treatment.
Mikhailova TL; Sishkova E; Poniewierka E; Zhidkov KP; Bakulin IG; Kupcinskas L; Lesniakowski K; Grinevich VB; Malecka-Panas E; Ardizzone S; D'Arienzo A; Valpiani D; Koch M; Denapiene G; Vago G; Fociani P; Zerbi P; Ceracchi M; Camerini R; Gasbarrini G
Aliment Pharmacol Ther; 2011 Nov; 34(9):1088-97. PubMed ID: 21929562
[TBL] [Abstract][Full Text] [Related]
4. Tumour necrosis factor alpha down-regulation parallels inflammatory regression in ulcerative colitis patients treated with infliximab.
Hassan C; Ierardi E; Burattini O; De Francesco V; Zullo A; Stoppino G; Panella C; Morini S
Dig Liver Dis; 2007 Sep; 39(9):811-7. PubMed ID: 17652038
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic effects of L-carnitine and propionyl-L-carnitine on cardiovascular diseases: a review.
Ferrari R; Merli E; Cicchitelli G; Mele D; Fucili A; Ceconi C
Ann N Y Acad Sci; 2004 Nov; 1033():79-91. PubMed ID: 15591005
[TBL] [Abstract][Full Text] [Related]
6. Mesalamine once daily is more effective than twice daily in patients with quiescent ulcerative colitis.
Dignass AU; Bokemeyer B; Adamek H; Mross M; Vinter-Jensen L; Börner N; Silvennoinen J; Tan G; Pool MO; Stijnen T; Dietel P; Klugmann T; Vermeire S; Bhatt A; Veerman H
Clin Gastroenterol Hepatol; 2009 Jul; 7(7):762-9. PubMed ID: 19375519
[TBL] [Abstract][Full Text] [Related]
7. The effect of a new symbiotic formulation on plasma levels and peripheral blood mononuclear cell expression of some pro-inflammatory cytokines in patients with ulcerative colitis: a pilot study.
Federico A; Tuccillo C; Grossi E; Abbiati R; Garbagna N; Romano M; Tiso A; Blanco Cdel V; Loguercio C
Eur Rev Med Pharmacol Sci; 2009; 13(4):285-93. PubMed ID: 19694343
[TBL] [Abstract][Full Text] [Related]
8. Safety and efficacy of a new 3.3 g b.i.d. tablet formulation in patients with mild-to-moderately-active ulcerative colitis: a multicenter, randomized, double-blind, placebo-controlled study.
Scherl EJ; Pruitt R; Gordon GL; Lamet M; Shaw A; Huang S; Mareya S; Forbes WP
Am J Gastroenterol; 2009 Jun; 104(6):1452-9. PubMed ID: 19491859
[TBL] [Abstract][Full Text] [Related]
9. Clinical trial: randomized-controlled clinical study comparing the efficacy and safety of a low-volume vs. a high-volume mesalazine foam in active distal ulcerative colitis.
Eliakim R; Tulassay Z; Kupcinskas L; Adamonis K; Pokrotnieks J; Bar-Meir S; Lavy A; Mueller R; Greinwald R; Chermesh I; Gross V;
Aliment Pharmacol Ther; 2007 Nov; 26(9):1237-49. PubMed ID: 17944738
[TBL] [Abstract][Full Text] [Related]
10. Mucosal features and granulocyte-monocyte-apheresis in steroid-dependent/refractory ulcerative colitis.
D'Ovidio V; Aratari A; Viscido A; Marcheggiano A; Papi C; Capurso L; Caprilli R
Dig Liver Dis; 2006 Jun; 38(6):389-94. PubMed ID: 16569521
[TBL] [Abstract][Full Text] [Related]
11. Treating ulcerative colitis by Adacolumn therapeutic leucocytapheresis: clinical efficacy and safety based on surveillance of 656 patients in 53 centres in Japan.
Hibi T; Sameshima Y; Sekiguchi Y; Hisatome Y; Maruyama F; Moriwaki K; Shima C; Saniabadi AR; Matsumoto T
Dig Liver Dis; 2009 Aug; 41(8):570-7. PubMed ID: 19211314
[TBL] [Abstract][Full Text] [Related]
12. Carnitine versus androgen administration in the treatment of sexual dysfunction, depressed mood, and fatigue associated with male aging.
Cavallini G; Caracciolo S; Vitali G; Modenini F; Biagiotti G
Urology; 2004 Apr; 63(4):641-6. PubMed ID: 15072869
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and tolerability of olsalazine (dipentum) in the treatment of patients with ulcerative colitis--results of a field study.
Singer MV; Schmausser H; Schönfeld G
Hepatogastroenterology; 2006; 53(69):317-21. PubMed ID: 16795963
[TBL] [Abstract][Full Text] [Related]
14. Effects of propionyl-L-carnitine on peripheral arterial obliterative disease of the lower limbs: a double-blind clinical trial.
Dal Lago A; De Martini D; Flore R; Gaetani E; Gasbarrini A; Gerardino L; Pola R; Santoliquido A; Serricchio M; Tondi P; Nolfe G
Drugs Exp Clin Res; 1999; 25(1):29-36. PubMed ID: 10337502
[TBL] [Abstract][Full Text] [Related]
15. Effect of once- or twice-daily MMX mesalamine (SPD476) for the induction of remission of mild to moderately active ulcerative colitis.
Lichtenstein GR; Kamm MA; Boddu P; Gubergrits N; Lyne A; Butler T; Lees K; Joseph RE; Sandborn WJ
Clin Gastroenterol Hepatol; 2007 Jan; 5(1):95-102. PubMed ID: 17234558
[TBL] [Abstract][Full Text] [Related]
16. The effect of acute psychologic stress on systemic and rectal mucosal measures of inflammation in ulcerative colitis.
Mawdsley JE; Macey MG; Feakins RM; Langmead L; Rampton DS
Gastroenterology; 2006 Aug; 131(2):410-9. PubMed ID: 16890594
[TBL] [Abstract][Full Text] [Related]
17. Delayed-release oral mesalamine at 4.8 g/day (800 mg tablet) for the treatment of moderately active ulcerative colitis: the ASCEND II trial.
Hanauer SB; Sandborn WJ; Kornbluth A; Katz S; Safdi M; Woogen S; Regalli G; Yeh C; Smith-Hall N; Ajayi F
Am J Gastroenterol; 2005 Nov; 100(11):2478-85. PubMed ID: 16279903
[TBL] [Abstract][Full Text] [Related]
18. Tissue levels of tumor necrosis factor-alpha correlates with grade of inflammation in untreated ulcerative colitis.
Olsen T; Goll R; Cui G; Husebekk A; Vonen B; Birketvedt GS; Florholmen J
Scand J Gastroenterol; 2007 Nov; 42(11):1312-20. PubMed ID: 17852866
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the efficacy of propionyl-L-carnitine versus pulsed muscular compressions in diabetic and non-diabetic patients affected by obliterating arteriopathy Leriche stage II.
Riccioni C; Sarcinella R; Palermo G; Izzo A; Liguori M; Koverech A; Messano M; Virmani A
Int Angiol; 2008 Jun; 27(3):253-9. PubMed ID: 18506129
[TBL] [Abstract][Full Text] [Related]
20. Once daily MMX mesalazine for the treatment of mild-to-moderate ulcerative colitis: a phase II, dose-ranging study.
D'Haens G; Hommes D; Engels L; Baert F; van der Waaij L; Connor P; Ramage J; Dewit O; Palmen M; Stephenson D; Joseph R
Aliment Pharmacol Ther; 2006 Oct; 24(7):1087-97. PubMed ID: 16984503
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
